205 related articles for article (PubMed ID: 9916332)
1. [French system of drug surveillance].
Imbs JL; Castot A; Begaud B; Larousse C; Blayac JP; Alexandre JM
Bull Acad Natl Med; 1998; 182(7):1383-91; discussion 1392-3. PubMed ID: 9916332
[TBL] [Abstract][Full Text] [Related]
2. [The French pharmacovigilance system: structure and missions].
Welsch M; Alt M; Richard MH; Imbs JL
Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040
[TBL] [Abstract][Full Text] [Related]
3. [Organization and results of drug vigilance in France].
Bégaud B; Chaslerie A; Haramburu F
Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
[TBL] [Abstract][Full Text] [Related]
4. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].
Aguirre C; Haramburu F
Therapie; 1995; 50(6):563-9. PubMed ID: 8745957
[TBL] [Abstract][Full Text] [Related]
5. Current French system of post-marketing drug surveillance.
Albengres E; Gauthier F; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):312-4. PubMed ID: 2387656
[TBL] [Abstract][Full Text] [Related]
6. Features of the French postmarketing drug surveillance system. Application to cutaneous effects of nonsteroidal antiinflammatory drugs.
Albengres E
J Rheumatol Suppl; 1988 Oct; 17():20-3. PubMed ID: 3204616
[TBL] [Abstract][Full Text] [Related]
7. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
Olivier P; Montastruc JL
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
[TBL] [Abstract][Full Text] [Related]
8. The role of databases in drug postmarketing surveillance.
Rodriguez EM; Staffa JA; Graham DJ
Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
[TBL] [Abstract][Full Text] [Related]
9. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
Fleuranceau-Morel P
Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
11. [Proposal of guidelines for the set-up of pharmaco-epidemiologic studies in drug surveillance].
de Tricornot B; Saddier P; Bons B; Clément JP; Courtand M; Lamarque V; Thomas A; Tomczyk S; Vaissère J
Therapie; 1997; 52(6):579-85. PubMed ID: 9734111
[TBL] [Abstract][Full Text] [Related]
12. [The need for 'postmarketing surveillance'].
Stricker BH; in 't Veld BA; Feenstra J
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):711-3. PubMed ID: 10347624
[TBL] [Abstract][Full Text] [Related]
13. Updating the French method for the causality assessment of adverse drug reactions.
Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults.
Hilmer SN; Gnjidic D; Abernethy DR
J Gerontol A Biol Sci Med Sci; 2012 Feb; 67(2):181-8. PubMed ID: 21653991
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccination and multiple sclerosis: a data mining perspective.
Hauben M; Sakaguchi M; Patadia V; M Gerrits C
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):943-5. PubMed ID: 17636551
[No Abstract] [Full Text] [Related]
16. [Drug surveillance: concepts, objectives, and methods].
Susano RC; Laborinho Fialho L; de Quirós JF
Acta Med Port; 1992 Dec; 5(11):595-602. PubMed ID: 1293954
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacoepidemiology. An unappreciated tool].
Vasen W; Fiorentino RM
Medicina (B Aires); 2006; 66(3):257-62. PubMed ID: 16871916
[TBL] [Abstract][Full Text] [Related]
18. Reporting of fatal adverse drug reactions.
Liu BA; Knowles SR; Mittmann N; Einarson T; Shear NH
Can J Clin Pharmacol; 2001; 8(2):84-8. PubMed ID: 11493936
[TBL] [Abstract][Full Text] [Related]
19. Provision of information on regulatory authorities' websites.
Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
[TBL] [Abstract][Full Text] [Related]
20. [Regional Centers of Pharmacovigilance: a complementary source of efficiency].
Mazé F; Bégaud B
Therapie; 1998; 53(4):397-400. PubMed ID: 9806011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
